• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在纳升输入体积的三维人体组织培养中测量葡萄糖消耗和糖异生作用。

Measuring Glucose Consumption and Gluconeogenesis in 3D Human Tissue Cultures with Nanoliter Input Volumes.

作者信息

Kemas Aurino M, Lauschke Volker M

机构信息

Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.

Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany.

出版信息

Methods Mol Biol. 2022;2445:337-349. doi: 10.1007/978-1-0716-2071-7_21.

DOI:10.1007/978-1-0716-2071-7_21
PMID:34973002
Abstract

Organotypic and microphysiological culture of primary human tissues and cancers has emerged as a powerful set of technologies that allow to faithfully mimic cellular metabolism and functions ex vivo. The predominant 3D culture methods include spheroids and microfluidic chips. These cultures use low cell numbers and culture volumes, which, however, poses important limitations for the available amounts of sample for downstream analyses. Here, we describe a detailed method for the measurement of glucose consumption dynamics in organotypic culture using a bienzymatic colorimetric assay that accurately quantifies glucose levels using nanoliter input volumes. As an example we utilize spheroids consisting of primary human hepatocytes. The assay has been carefully optimized and benchmarked and is compatible with both longitudinal and high-throughput screening in both static and perfused conditions. The method is straightforward and only requires a microplate reader capable of running absorbance kinetic measurements.

摘要

原代人组织和癌症的器官型及微生理培养已成为一套强大的技术,能够在体外忠实地模拟细胞代谢和功能。主要的3D培养方法包括球体培养和微流控芯片。这些培养方法使用的细胞数量和培养体积较少,然而,这对用于下游分析的样本量造成了重要限制。在此,我们描述了一种详细的方法,用于通过双酶比色法测量器官型培养中的葡萄糖消耗动态,该方法使用纳升输入体积准确量化葡萄糖水平。作为示例,我们利用由原代人肝细胞组成的球体。该测定方法经过精心优化和基准测试,适用于静态和灌注条件下的纵向和高通量筛选。该方法简单直接,仅需要一台能够进行吸光度动力学测量的微孔板读数器。

相似文献

1
Measuring Glucose Consumption and Gluconeogenesis in 3D Human Tissue Cultures with Nanoliter Input Volumes.在纳升输入体积的三维人体组织培养中测量葡萄糖消耗和糖异生作用。
Methods Mol Biol. 2022;2445:337-349. doi: 10.1007/978-1-0716-2071-7_21.
2
Insulin-dependent glucose consumption dynamics in 3D primary human liver cultures measured by a sensitive and specific glucose sensor with nanoliter input volume.通过具有纳升级输入体积的灵敏且特异的葡萄糖传感器测量 3D 原代人肝培养物中胰岛素依赖性葡萄糖消耗动力学。
FASEB J. 2021 Mar;35(3):e21305. doi: 10.1096/fj.202001989RR.
3
Glucose and lipid metabolism screening models of hepatocyte spheroids after culture with injectable fiber fragments.注射用纤维片段培养后肝细胞球体的葡萄糖和脂质代谢筛选模型
J Tissue Eng Regen Med. 2020 Jun;14(6):774-788. doi: 10.1002/term.3042. Epub 2020 Apr 19.
4
Establishment of Microfluidic Spheroid Cultures for Biomedical Applications.用于生物医学应用的微流控球体培养的建立。
Methods Mol Biol. 2018;1771:213-224. doi: 10.1007/978-1-4939-7792-5_17.
5
An oxygen-permeable spheroid culture system for the prevention of central hypoxia and necrosis of spheroids.一种用于预防球体中心缺氧和坏死的透气球体培养系统。
Biomaterials. 2012 Nov;33(33):8430-41. doi: 10.1016/j.biomaterials.2012.08.040. Epub 2012 Aug 30.
6
A multi-organ-chip co-culture of liver and testis equivalents: a first step toward a systemic male reprotoxicity model.多器官芯片共培养的肝和睾丸等效物:迈向系统性男性生殖毒性模型的第一步。
Hum Reprod. 2020 May 1;35(5):1029-1044. doi: 10.1093/humrep/deaa057.
7
High-throughput microfluidics for evaluating microbubble enhanced delivery of cancer therapeutics in spheroid cultures.高通量微流控技术评估微泡增强的癌症治疗剂在球体培养物中的传递。
J Control Release. 2020 Oct 10;326:13-24. doi: 10.1016/j.jconrel.2020.06.011. Epub 2020 Jun 17.
8
Detachably assembled microfluidic device for perfusion culture and post-culture analysis of a spheroid array.可拆分组装式微流控装置,用于球状体阵列的灌注培养和培养后分析。
Biotechnol J. 2014 Jul;9(7):971-9. doi: 10.1002/biot.201300559. Epub 2014 Jun 12.
9
Analysis of the behavior of 2D monolayers and 3D spheroid human pancreatic beta cells derived from induced pluripotent stem cells in a microfluidic environment.在微流控环境中分析诱导多能干细胞衍生的 2D 单层和 3D 球体人胰腺β细胞的行为。
J Biotechnol. 2021 Mar 20;330:45-56. doi: 10.1016/j.jbiotec.2021.02.009. Epub 2021 Feb 19.
10
A high-throughput, open-space and reusable microfluidic chip for combinational drug screening on tumor spheroids.高通量、开放式且可重复使用的微流控芯片,用于肿瘤球体的组合药物筛选。
Lab Chip. 2021 Oct 12;21(20):3924-3932. doi: 10.1039/d1lc00525a.

本文引用的文献

1
Insulin-dependent glucose consumption dynamics in 3D primary human liver cultures measured by a sensitive and specific glucose sensor with nanoliter input volume.通过具有纳升级输入体积的灵敏且特异的葡萄糖传感器测量 3D 原代人肝培养物中胰岛素依赖性葡萄糖消耗动力学。
FASEB J. 2021 Mar;35(3):e21305. doi: 10.1096/fj.202001989RR.
2
Inhibitors in Commercially Available 2,2'-Azino-bis(3-ethylbenzothiazoline-6-sulfonate) Affect Enzymatic Assays.市售的 2,2'-偶氮双(3-乙基苯并噻唑啉-6-磺酸)抑制剂会影响酶促测定。
Anal Chem. 2020 Jan 7;92(1):1502-1510. doi: 10.1021/acs.analchem.9b04751. Epub 2019 Dec 18.
3
Organotypic and Microphysiological Models of Liver, Gut, and Kidney for Studies of Drug Metabolism, Pharmacokinetics, and Toxicity.
用于药物代谢、药代动力学和毒性研究的肝脏、肠道和肾脏的器官型及微生理模型。
Chem Res Toxicol. 2020 Jan 21;33(1):38-60. doi: 10.1021/acs.chemrestox.9b00245. Epub 2019 Oct 17.
4
The roles of glucose metabolic reprogramming in chemo- and radio-resistance.葡萄糖代谢重编程在化疗和放疗抵抗中的作用。
J Exp Clin Cancer Res. 2019 May 23;38(1):218. doi: 10.1186/s13046-019-1214-z.
5
Human hepatic 3D spheroids as a model for steatosis and insulin resistance.人源肝 3D 球体作为脂肪变性和胰岛素抵抗的模型。
Sci Rep. 2018 Sep 24;8(1):14297. doi: 10.1038/s41598-018-32722-6.
6
Application of Microphysiological Systems to Enhance Safety Assessment in Drug Discovery.微生理系统在药物发现中增强安全性评估的应用。
Annu Rev Pharmacol Toxicol. 2018 Jan 6;58:65-82. doi: 10.1146/annurev-pharmtox-010617-052722. Epub 2017 Oct 13.
7
3D tumor spheroids: an overview on the tools and techniques used for their analysis.3D 肿瘤球体:用于分析它们的工具和技术概述。
Biotechnol Adv. 2016 Dec;34(8):1427-1441. doi: 10.1016/j.biotechadv.2016.11.002. Epub 2016 Nov 11.
8
Characterization of primary human hepatocyte spheroids as a model system for drug-induced liver injury, liver function and disease.原代人肝细胞球状体作为药物性肝损伤、肝功能及疾病模型系统的特性研究
Sci Rep. 2016 May 4;6:25187. doi: 10.1038/srep25187.
9
Glucose-regulated proteins in cancer: molecular mechanisms and therapeutic potential.肿瘤中的葡萄糖调节蛋白:分子机制与治疗潜能。
Nat Rev Cancer. 2014 Apr;14(4):263-76. doi: 10.1038/nrc3701.
10
A novel 3D liver organoid system for elucidation of hepatic glucose metabolism.一种用于阐明肝脏葡萄糖代谢的新型 3D 类肝器官系统。
Biotechnol Bioeng. 2012 Feb;109(2):595-604. doi: 10.1002/bit.23349. Epub 2011 Oct 19.